US is the Largest Market for the Cardiovascular Surgery Devices with 46% of Global Share

Date: 2015-10-26

The prevalence of heart diseases globally increases the demand for interventional cardiology surgeries. The cardiology surgeries are costly and have some risk factor attached – there is 3-5% probability of patient’s death. The global increase in life style oriented diseases has indirectly put pressure on the economies of the nation. The patient alone does not bear the cost of the treatment. The funding comes from the government health programs, reimbursement policies and health insurances to enable the patient for getting treatment. 

US is the largest market for the Cardiovascular surgery devices with 46% of global share. Europe has captured 27% of market share in the cardiovascular surgery devices. APAC has largest growth in the market which mainly comes from the China and Japan.

Key Players
1. Abbott Cardiovascular
2. Boston Scientific Corp.
3. C.R. Bard, Inc.
4. Cook Medical
5. Medtronic. Inc
6. Toshiba Medical systems
7. Biosense Webster, Inc.
8. Edwards Lifescience Corp.
9. Lombard Medical, 
10. Atricure Inc., 
11. Atrium Medical Corporation.,
12.  Johnson And Johnson, 
13. GE Healthcare (Interventional Imaging) , 
14. Philips Healthcare(Interventional Imaging), 
15. Smiths Medical(Interventional Imaging), 
16. St. Judes Medical, 
17. Hansen Medical, 
18. Berlin Heart, 
19. Cambridge Heart

Contact With Us
Join templatemonster at google+
Customized Research
Request Sample